Adma Biologics Insider Trades $300K In Company Stock

Joseph Edelman, 10% Owner at Adma Biologics ADMA, made a large insider sell on September 30, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Edelman sold 260,603 shares of Adma Biologics at prices ranging from $1.12 to $1.22. The total transaction amounted to $299,236.

Edelman still owns a total of 13,262,375 shares of Adma Biologics worth, $14,978,526.

Adma Biologics shares are trading down 0.05% at $1.13 at the time of this writing on Friday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Why Insider Transactions Are Important

Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Important Transaction Codes

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Adma Biologics's Insider Trades.